Novartis

No sanctions for Novartis as FDA ends review of gene therapy violations
BioSpace
Tue, 03/31/20 - 11:14 am
Novartis
AveXis
Zolgensma
data manipulation
A Baby’s Milestones and the Next Steps for Novartis in Gene Therapy
Xconomy
Tue, 03/31/20 - 10:49 am
SMA
Novartis
gene therapy
Zolgensma
ACC: New owner Novartis presents pooled inclisiran data cutting LDL cholesterol by half
Fierce Biotech
Sat, 03/28/20 - 11:43 pm
Novartis
ACC
PCSK9 inhibitors
inclisiran
Pharma giants including Novartis collaborate on COVID-19 therapies
Pharmaforum
Thu, 03/26/20 - 10:38 am
JNJ
Novartis
Boehringer Ingelheim
Biomerieux
Eisai
Eli Lilly
Gilead Sciences
GSK
Merck
Merck KGaA
Pfizer
Sanofi
R&D
COVID-19
diagnostics
vaccines
Novartis escapes one set of kickback allegations, but federal charges roll on
Fierce Pharma
Wed, 03/25/20 - 11:38 am
Novartis
Gilenya
kickbacks
whistleblower lawsuits
ethics
In two-man race with Novartis, Merck scores first regulatory approval for targeted lung cancer drug
Endpoints
Wed, 03/25/20 - 10:45 am
Novartis
Merck KGaA
Japan
tepotinib
non-small cell lung cancer
Novartis publishes long-term data from SMA gene therapy
Pharmaforum
Tue, 03/24/20 - 10:31 am
Novartis
Zolgensma
gene therapy
SMA
Novartis recalls immunosuppressant Sandimmune, Neoral capsules for hazardous packaging
Fierce Pharma
Thu, 03/19/20 - 11:35 pm
Novartis
Sandimmune
Neoral
product recalls
Novartis posts pivotal data ahead of FDA decision on $9.7B bet
Fierce Biotech
Thu, 03/19/20 - 11:04 am
Novartis
inclisiran
clinical trials
FDA
Novartis launches $20m COVID-19 response fund
PM Live
Wed, 03/18/20 - 10:33 am
Novartis
COVID-19
grants
Public Health
New sickle cell drugs priced too high, ICER says
BioPharma Dive
Fri, 03/13/20 - 12:43 pm
sickle cell disease
drug pricing
ICER
Novartis
Global Blood Therapeutics
RWE
Adakveo
Oxbryta
Novartis sidesteps Europe travel ban to provide CAR-T drug Kymriah to patients
Fierce Pharma
Fri, 03/13/20 - 12:41 pm
Novartis
Europe
Donald Trump
gene therapy
Kymriah
COVID-19
FDA approves ex-Novartis drug for Cushing’s disease
Endpoints
Mon, 03/9/20 - 10:17 am
FDA
Cushing's disease
Isturisa
Novartis
Recordati
Novartis taps Orionis to pursue 'historically elusive targets'
Fierce Biotech
Thu, 03/5/20 - 10:55 am
Novartis
Orionis Biosciences
drug discovery
'Lightning struck': How a safety alert shifted doctor sentiment on Novartis' Beovu
Fierce Pharma
Wed, 03/4/20 - 10:57 am
Novartis
Beovu
ASRS
occlusive vasculitis
wet age-related macular degeneration
physicians
With one rival down, Novartis-partnered biotech scores $100M round to fund mid-stage trials of fibrosis drug
Endpoints
Tue, 03/3/20 - 11:02 am
Pliant Therapeutics
IPF
Biogen
Novartis
Sandoz Pays $195 Million to Settle Criminal Antitrust Charges in Sweeping Federal Probe
BioSpace
Tue, 03/3/20 - 10:55 am
Sandoz
generics
Novartis
antitrust
Morphosys’ off-the-shelf rival to CAR-T approaches finish line with a speedy review
Endpoints
Mon, 03/2/20 - 09:37 am
MorphoSys
Gilead Sciences
Novartis
CAR-T
tafasitamab
DLBCL
Novartis knocked by safety scare
EP Vantage
Tue, 02/25/20 - 04:55 pm
Novartis
Regeneron
Beovu
Eylea
wet age-related macular degeneration
Novartis' hot new eye drug Beovu tied to potential vision loss: experts
Fierce Pharma
Tue, 02/25/20 - 10:02 am
Novartis
Beovu
retinal vasculitis
wet age-related macular degeneration

Pages